[Long-term prognosis for colorectal carcinoma treated with adjuvant immunochemotherapy].
Sakai
Toshimi
T
Second Department of Surgery, School of Medicine, Fukuoka University.
Yamashita
Yuichi
Y
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D003082:Colectomy; D015179:Colorectal Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D016207:Cytokines / Q000096:biosynthesis; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use*; D008213:Lymphocyte Activation / Q000187:drug effects; D011379:Prognosis; D011509:Proteoglycans / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors
D000964:Antimetabolites, Antineoplastic; D016207:Cytokines; D007155:Immunologic Factors; D011509:Proteoglycans; C010770:polysaccharide-K; D005472:Fluorouracil